Completed PHASE3 INTERVENTIONAL 2-arm NCT00904501

Bone Marrow Autograft in Limb Ischemia (BALI)

Cell Therapy in Critical Limb Ischemia

Sponsor: CHU de Reims

Updated 6 times since 2017 Last updated: Mar 5, 2016 Started: Mar 31, 2009 Primary completion: Jan 31, 2015 Completion: Jan 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Peripheral Vascular Diseases, this trial is completed. The trial is conducted by CHU de Reims and has accumulated 6 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Mar 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CHU de Reims
Etablissement Français du Sang

Data source: CHU de Reims

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Amiens, France , Besançon, France , Bordeaux, France , Caen, France , Grenoble, France , Lille, France , Limoges, France , Marseille, France , Mulhouse, France , Nancy, France and 4 more locations